Get started
Author

Maurizio Cavallari

Observed name: CAVALLARI, Maurizio
ORCID: 0000-0001-6697-5773
Observed ORCID: 0000-0001-6697-5773
OpenAlex ID: A5008701337
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI
2017 · Gian Matteo Rigolin, Maurizio Cavallari, et al. · Blood · 102
PDF
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
2021 · Andrea Visentin, Laura Bonaldi, et al. · Haematologica · 62
PDF
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia
2019 · Andrea Visentin, Laura Bonaldi, et al. · British Journal of Cancer · 45
PDF
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
2018 · Gian Matteo Rigolin, Elena Saccenti, et al. · British Journal of Haematology · 45
PDF
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
2016 · Gian Matteo Rigolin, Elena Saccenti, et al. · Journal of Hematology & Oncology · 42
PDF
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations
2015 · Gian Matteo Rigolin, Ilaria del Giudice, et al. · Genes Chromosomes and Cancer · 40
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
2018 · Maurizio Cavallari, Francesco Cavazzini, et al. · Oncotarget · 26
PDF
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion
2016 · Francesco Cavazzini, Enrico Lista, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 21
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
2017 · Gian Matteo Rigolin, Luca Formigaro, et al. · Oncotarget · 14
PDF
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study
2020 · Antonio Cuneo, Anthony R. Mato, et al. · Cancer Medicine · 13
PDF
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients
2013 · Gian Matteo Rigolin, Elena Saccenti, et al. · Oncotarget · 13
PDF
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”
2017 · Maurizio Cavallari, Maria Ciccone, et al. · Leukemia Research Reports · 11
PDF
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome
2020 · Gian Matteo Rigolin, Elena Saccenti, et al. · British Journal of Haematology · 9
A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
2020 · Mariarosaria Sessa, Francesco Cavazzini, et al. · Genes · 8
PDF
Delirium in acute promyelocytic leukemia patients: two case reports
2013 · Gian Matteo Rigolin, Sara Martinelli, et al. · BMC Research Notes · 6
PDF
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib
2015 · Maria Ciccone, Maurizio Cavallari, et al. · Blood · 5
Optimal Management of Chronic Lymphocytic Leukemia and Economic Constraints
2021 · Antonio Cuneo, Francesco Cavazzini, et al. · The Cancer Journal · 3
An Extensive Molecular Cytogenetic Characterization in High-risk Chronic Lymphocytic Leukemia Identifies Karyotype Aberrations and Tp53 Disruption as Predictors of Outcome and Chemorefractoriness
2017 · Gian Matteo Rigolin, Luca Formigaro, et al. · Institutional Research Information System University of Ferrara (University of Ferrara) · 1
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
2016 · Gian Matteo Rigolin, Elena Saccenti, et al. · Journal of Hematology & Oncology · 1
PDF
Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up
2026 · Andrea Visentin, Alessandro Cellini, et al. · EClinicalMedicine
Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive study
2025 · Andrea Visentin, Thomas Chatzikonstantinou, et al. · Blood
PDF
P1183: Central Nervous System Involvement at Diagnosis and at Relapse in Patients With Peripheral T-cell Lymphoma: a Retrospective Analysis of the “rete Ematologica Veneta” (t-rev Project).
2023 · Marcello Riva, Maria Chiara Tisi, et al. · HemaSphere
The Combination of Complex Karyotypes' Subtypes and IGHV Mutational Status Provides Prognostic and Predictive Information in Chronic Lymphocytic Leukemia
2018 · Andrea Visentin, Laura Bonaldi, et al. · Blood
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors
2015 · Sara Martinelli, Maurizio Cavallari, et al. · Blood
Works count: 25
Citation count: 467
H-index: 11
I10-index: 12
Year
Topic
Type